Defective antigen presentation to a cloned T helper cell by macrophages from burned mice can be restored with interleukin-1

Autor: Ts, Kupper, Dr, Green, scott durum, Cc, Baker

Publikováno v: Europe PubMed Central

T helper (Th) cell dysfunction occurring very early (i.e., 24 to 72 hours) after a 30% full-thickness burn in a murine model cannot be attributed to suppressor T cell activity. Th cell activity is influenced by the activity of antigen-presenting cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eb3554e60cfcf201524b0a6f3178f210
https://pubmed.ncbi.nlm.nih.gov/3161195

Primary cutaneous EBV+ extranodal NK/T-cell lymphoma of gamma/delta T-cell lineage in the posttransplantation setting.

Autor: Williams JF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lucas FM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Carrasco RD; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Kupper TS; Department of Dermatology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Sadigh S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Journal of cutaneous pathology [J Cutan Pathol] 2024 Oct; Vol. 51 (10), pp. 777-782. Date of Electronic Publication: 2024 Jul 10.

Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.

Autor: Yu Z; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Vieyra-Garcia P; Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Benezeder T; Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria., Crouch JD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kim IR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., O'Malley JT; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Devlin PM; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Gehad A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zhan Q; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gudjonsson JE; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA., Sarkar MK; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA., Kahlenberg JM; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Gerard N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Teague JE; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kupper TS; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Larocca C; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Tawa M; Center for Cutaneous Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Pomahac B; Division of Plastic and Reconstructive Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA., Talbot SG; Division of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Orgill DP; Division of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wolf P; Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Electronic address: peter.wolf@medunigraz.at., Clark RA; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: rclark@bwh.harvard.edu.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2024 Mar; Vol. 144 (3), pp. 621-632.e1. Date of Electronic Publication: 2023 Sep 15.

Resident memory T cell development is associated with AP-1 transcription factor upregulation across anatomical niches.

Autor: Smith NP, Yan Y, Pan Y, Williams JB, Manakongtreecheep K, Pant S, Zhao J, Tian T, Pan T, Stingley C, Wu K, Zhang J, Kley AL, Sorger PK, Villani AC, Kupper TS

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 02. Date of Electronic Publication: 2023 Oct 02.

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma.

Autor: Virgen CA; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sparks JA; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA., Nohria A; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., O'Hare MJ; Harvard Medical School, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Goyal A; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA., Said JT; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Tawa M; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kupper TS; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fisher DC; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Larocca C; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publikováno v: The oncologist [Oncologist] 2023 Aug 03; Vol. 28 (8), pp. e694-e698.